EUVIMEDEUVIMED entdecken
Crossref

Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection

Zihai Wang, Tong Wang, Kaiqiang Qian, Bikui Tang, Jun Xi

Current Microbiology · 2026

DOI: 10.1007/s00284-025-04557-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Zihai Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Manganese, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Anhui Province Key Laboratory of Immunology in Chronic Diseases Foundation, Bengbu Medical University Natural Science Foundation, Anhui Educational Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (Mtb), a highly infectious intracellular pathogen, is the primary causative agent of tuberculosis (TB), which ranks as the leading cause of death from individual infectious agents. In this context, we developed a model using macrophages infected with M. smegmatis mc2155 and Mtb H37Ra to elucidate the role of Mn2+ in host defense against tuberculosis infection. Treatment with a combination of anti-tuberculosis drugs and Mn2+ for 36 h markedly reduced the survival of intracellular bacteria, and the addition of Mn2+ significantly enhanced the secretion of TNF-α and IL-1β. In mice infected with Mtb H37Ra, treatment with Mn2+ (2 mg/kg) and the combination of Isoniazid and Mn2+ significantly increased serum TNF-α levels, with the combination treatment showing a more pronounced effect. Histopathological analysis indicated a relatively diminished immune response in the spleen in the drug and Mn2+treatment groups, while the immune response in the lungs was comparable across all groups. Mn2+ can synergistically enhance the efficacy of anti-tuberculosis drugs by activating cellular secretion of immune factors and inhibiting the growth of Mtb. The findings of this study provide a rationale for the potential use of Mn2+ as an activator of cellular immunity against Mtb infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ManganeseMycobacterium tuberculosisTuberculosisAnimalsMiceMacrophagesAntitubercular AgentsTumor Necrosis Factor-alphaDisease Models, AnimalIsoniazidLungFemaleInterleukin-1betaMice, Inbred BALB CHumans

Substanzen

ManganeseAntitubercular AgentsTumor Necrosis Factor-alphaIsoniazidInterleukin-1beta

Autor:innen und Institutionen

  • College of Life Science, Bengbu Medical University, Bengbu, China.
  • College of Life Science, Bengbu Medical University, Bengbu, China. bikui_tang@163.com.
  • Anhui Province Key Laboratory of Immunology in Chronic Diseases, Bengbu, China. bikui_tang@163.com.
  • College of Life Science, Bengbu Medical University, Bengbu, China. luckymq2014@foxmail.com.

Förderung

  • Anhui Province Key Laboratory of Immunology in Chronic Diseases Foundation
  • Bengbu Medical University Natural Science Foundation
  • Anhui Educational Committee
  • Longhu Talent Project of Bengbu Medical University

Zitieren

APA

Wang, Z., Wang, T., Qian, K., Tang, B., & Xi, J. (2026). Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection. Current Microbiology. https://doi.org/10.1007/s00284-025-04557-8

Vancouver

Wang Z, Wang T, Qian K, Tang B, Xi J. Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection. Current Microbiology. 2026. doi:10.1007/s00284-025-04557-8

BibTeX
@article{Wang2026,
  author = {Wang, Zihai and Wang, Tong and Qian, Kaiqiang and Tang, Bikui and Xi, Jun},
  title = {Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection},
  journal = {Current Microbiology},
  year = {2026},
  doi = {10.1007/s00284-025-04557-8}
}
Kostenlos starten →